StockDuty ← Dashboard Oct 06, 2026 01:16 PM ET
SignalFDA/Bio

Vaxcyte stock surged after its pneumococcal vaccine passed a key phase 3 test

Vaxcyte surged on positive phase 3 pneumococcal vaccine results.

Vaxcyte surged on positive phase 3 pneumococcal vaccine results.
Vaxcyte surged on positive phase 3 pneumococcal vaccine results. — impact context not separately stored; see What changed.
Sources